Bioporto A/S

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: DK0011048619
DKK
1.13
-0.05 (-3.9%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Bioporto A/S Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
-73.00
-61.00
-81.00
-63.00
-66.00
-74.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-13.00
-4.00
10.00
-7.00
15.00
4.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-83.00
-55.00
-52.00
-64.00
-35.00
-60.00
Cash Flow from Investing Activities
1.00
0.00
0.00
0.00
-1.00
-2.00
Cash Flow from Financing Activities
75.00
40.00
88.00
1.00
127.00
33.00
Net Cash Inflow / Outflow
-6.00
-15.00
36.00
-62.00
89.00
-28.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
1.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in DKK Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Bioporto A/S
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(DKK)
Change(%)
Profit Before Tax
-73.743
176.586
-249.00
-141.76%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-13.452
-13.11
0.00
-2.61%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-83.583
129.002
-212.00
-164.79%
Cash Flow from Investing Activities
1.187
-43.494
44.00
102.73%
Cash Flow from Financing Activities
75.466
-105.715
180.00
171.39%
Net Cash Inflow / Outflow
-6.738
-20.425
14.00
67.01%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0.192
-0.218
0.00
188.07%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
stock-summary

YoY Growth in year ended Dec 2024 is -50.72% vs -5.66% in Dec 2023

Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
-83.58
-55.46
-50.72%